<DOC>
	<DOCNO>NCT00521690</DOCNO>
	<brief_summary>The trial conduct Asia . The aim trial evaluate effect insulin detemir blood glucose control Taiwanese patient type 2 diabetes fail OAD with/without once-daily NPH Insulin treatment .</brief_summary>
	<brief_title>The Effect Insulin Detemir Blood Glucose Control Taiwanese Patients With Type 2 Diabetes Failing OAD</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 2 diabetes HbA1C : 7.011.0 % Previous diabetes treatment least 6 month BMI max . 35 kg/m2 Treatment oral antidiabetic drug ( OAD ) Type 1 diabetes Receipt investigational drug within last three month prior trial</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>